UMB Bank n.a. trimmed its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 18.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,474 shares of the company's stock after selling 776 shares during the period. UMB Bank n.a.'s holdings in McKesson were worth $2,546,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of MCK. Brighton Jones LLC grew its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock worth $1,438,000 after buying an additional 798 shares in the last quarter. Woodline Partners LP acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $1,891,000. Novem Group acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $205,000. Vise Technologies Inc. boosted its stake in shares of McKesson by 129.7% in the 4th quarter. Vise Technologies Inc. now owns 1,601 shares of the company's stock valued at $912,000 after purchasing an additional 904 shares in the last quarter. Finally, GF Fund Management CO. LTD. acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $1,848,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
McKesson Stock Up 6.6%
MCK stock traded up $46.11 during midday trading on Tuesday, reaching $743.11. 523,261 shares of the company's stock traded hands, compared to its average volume of 868,981. The company has a market cap of $92.43 billion, a price-to-earnings ratio of 29.61, a P/E/G ratio of 1.39 and a beta of 0.51. The firm's fifty day moving average price is $694.76 and its 200-day moving average price is $697.18. McKesson Corporation has a 52 week low of $464.42 and a 52 week high of $748.75.
McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.33 by ($0.07). The firm had revenue of $97.83 billion for the quarter, compared to analysts' expectations of $95.93 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.McKesson's revenue was up 23.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $7.88 earnings per share. Analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.
McKesson Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. This is a positive change from McKesson's previous quarterly dividend of $0.71. McKesson's payout ratio is presently 13.08%.
Analyst Upgrades and Downgrades
MCK has been the topic of a number of research analyst reports. Wells Fargo & Company raised their price target on shares of McKesson from $766.00 to $772.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 13th. Morgan Stanley reiterated an "overweight" rating and issued a $810.00 price objective (up previously from $770.00) on shares of McKesson in a report on Wednesday, July 16th. Wall Street Zen lowered shares of McKesson from a "buy" rating to a "hold" rating in a report on Saturday. Evercore ISI raised their price objective on shares of McKesson from $760.00 to $800.00 and gave the company an "outperform" rating in a report on Wednesday, July 9th. Finally, Cowen restated a "buy" rating on shares of McKesson in a report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, McKesson currently has an average rating of "Moderate Buy" and an average target price of $725.10.
Read Our Latest Research Report on McKesson
Insiders Place Their Bets
In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction on Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the transaction, the chief accounting officer directly owned 657 shares of the company's stock, valued at $436,031.19. The trade was a 33.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Brian S. Tyler sold 19,371 shares of McKesson stock in a transaction on Friday, July 11th. The stock was sold at an average price of $708.09, for a total transaction of $13,716,411.39. Following the transaction, the chief executive officer directly owned 27,872 shares in the company, valued at $19,735,884.48. This represents a 41.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,560 shares of company stock worth $30,438,602 over the last ninety days. Insiders own 0.08% of the company's stock.
McKesson Company Profile
(
Free Report)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
See Also
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
